| NCT ID | NCT07299487 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Vertigo |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-09-09 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-09-09 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Consultations for vertigo in general practice are difficult, primarily due to practitioners' lack of experience. Patient referrals can be inaccurate, leading to missed opportunities or misuse of resources. The creation of a diagnostic aid flowchart that provides referrals will improve patient care and reassure general practitioners during consultations for vertigo.
Eligibility Criteria
Inclusion Criteria: * Subject of legal age (≥18 years) * Having received initial care from a medical student and whose consultation data, interview, clinical examination, and diagnosis according to our decision tree were present in the patient file. * Patient for whom a definitive diagnosis was made by the on-call ENT physician during the same hospital visit. Exclusion Criteria: * Subject who expressed objection to the reuse of their data for scientific research. * Known chronic vestibular pathology * Incomplete patient medical file * Patient examined outside the ENT department.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07299487 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Vertigo. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07299487 currently recruiting?
Yes, NCT07299487 is actively recruiting participants. Contact the research team at guillaume.trau@chru-strasbourg.fr for enrollment information.
Where is the NCT07299487 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07299487 clinical trial?
NCT07299487 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 50 participants.